TTi Health Research & Economics

Accurate data analysis and reporting are crucial for interpreting study results. Here’s how we excel in this final phase: 📈 Data Management: We ensure data is accurately collected, verified, and entered into our systems. Our strategic team employs advanced data management techniques to ensure accuracy and reliability, unlike average CROs with standard practices. We also conduct thorough data validation to prevent errors. 📊 Statistical Analysis: We perform detailed statistical analysis based on your study’s plan. Our approach provides deeper insights and more robust interpretations compared to the basic analyses often provided by average CROs. We also offer expert consultations to interpret complex results. 📝 Clinical Study Report: We prepare comprehensive reports detailing study findings. Unlike average CROs who might offer generic reports, our strategic team customizes reports to highlight key insights and meet regulatory requirements. We also ensure the report is clear and accessible for all stakeholders. With our team’s in-depth expertise in data analysis and reporting, we deliver high-quality results and valuable insights for your clinical study. Next time we’ll cover market success (8/10)! Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

Managing and monitoring study data is crucial for ensuring accuracy and compliance. Here’s how we excel in this phase: 📊 Patient Recruitment: We implement targeted strategies to efficiently recruit and enroll participants. Our strategic team uses advanced recruitment methods tailored to your study’s needs, unlike average CROs with more generic approaches. We also provide regular updates on recruitment progress. 📋 Data Collection: We ensure meticulous data collection and management in line with the study protocol. Our strategic team provides rigorous oversight to maintain data integrity, distinguishing us from average CROs who may lack this level of detail. We also employ cutting-edge technology to enhance data accuracy. 🔍 Site Monitoring: We regularly monitor sites to ensure compliance and address issues promptly. Our proactive monitoring approach ensures adherence to protocols, while average CROs may only provide reactive support. We also conduct periodic audits to ensure high standards are maintained. Our team’s advanced data management expertise ensures the highest quality and reliability of your study results. Our next strategic clinical studies content (7/10) is all about synthesizing data findings. Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

🗣️ In Just Two Days❕ Our President & CEO, April Zambelli-Weiner, Ph.D., will be speaking at Austin MedTech Connect's Focus on the Founder event on Wednesday, October 23, from 5:00 PM to 9:00 PM CDT at Capital Factory in Austin, Texas. 👉 Registration & More Info: https://lu.ma/ncy5efqo Also an instructor, mentor, & research scientist at The Johns Hopkins Center for Bioengineering Innovation & Design, April will share her expertise as a senior healthcare leader, innovator, and entrepreneur. With her experience in launching and growing hundreds of products across diverse indication areas, attendees can expect valuable commercialization and research insights. 🔗 Joining her will be our VP of Client Relations, Fernanda Nusbaum, who will be there to connect and engage with everyone. ✨ We're thankful for this great opportunity to learn from other industry leaders and network with MedTech founders! Here's a little bit about what we do. 👇 #LifeSciencesSummit #HealthTech #MedTech #AustinMedTechSummit

As the AdvaMed conference begins, we want to highlight the advantages of our integrated approach to medical affairs, clinical research, & market access. 🚀Holistic Solutions: Unlike traditional CROs that operate in silos, our team offers a unified approach delivers comprehensive solutions tailored to your specific needs. We recently helped a client streamline their clinical trial processes while enhancing their market access strategy, resulting in a 30% reduction in time to market. This holistic strategy ensures that every element of your research is aligned with your strategic objectives, enhancing overall project success. 🔍Collaborative Team: Our multidisciplinary team works to provide integrated solutions & prioritize alignment with your broader business goals, drawing on insights from medical affairs, clinical research, & market access. We recently helped integrate a client’s existing market access data into their clinical study design, which significantly improved stakeholder buy-in and facilitated a smoother product launch. This approach ensures that your strategies effectively support adoption, value analysis, & implementation, addressing all research needs. 💡Strategic Integration: Our multidisciplinary expertise offers a strategic advantage that traditional CROs cannot match. Our integrated approach enables us to tackle adoption barriers and enhance market access effectively, drawing from our team's extensive experience in each discipline. Recently, we collaborated with a biotech firm to optimize their product's value proposition, which not only improved reimbursement outcomes but also strengthened their engagement with key opinion leaders at the same time. We provide the comprehensive support you need to drive successful outcomes and hitting your goals. 🌟Proven Track Record: Our commitment to excellence is demonstrated through our successful partnerships and tangible outcomes. By leveraging our deep industry knowledge and data analytics capabilities, we ensure that our clients can navigate complex regulatory environments and achieve their desired outcomes efficiently. This experience underscores our dedication to driving impactful results in every facet of medical affairs, clinical research, and market access. We're looking forward to meeting everyone in Toronto! We're excited to discuss how our integrated expertise can support your projects. 📆 Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/ePPJX-yn 📰 Share TTi's newsletter with your team. https://lnkd.in/eutCmYBW #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #CVD #Risk #Ethics

As we gear up for the AdvaMed MedTech Conference, we want to highlight our commitment to ethics and de-risking your MedTech studies. At TTi, we understand that effective research requires a streamlined approach tailored to your specific needs. 🚀Ethical Standards: We uphold the highest ethical standards across all our studies. Our dedicated team of compliance officers and research scientists ensures transparency, integrity, and compliance - crucial for the credibility and validity of your research. This rigorous approach guarantees that your studies adhere to the highest ethical benchmarks, fostering trust and reliability. 🔍Risk Management: Our de-risking strategies encompass thorough risk assessments and proactive mitigation plans. Our specialists conduct detailed analyses to identify potential issues and implement strategies to address them before they affect your research. This proactive approach minimizes uncertainties and enhances the reliability of your studies, giving you confidence in the robustness of your findings. 💲No Wasted Resources at AdvaMed: You won’t see us spending on an extravagant booth at the conference. Instead, we’ll be on the ground, actively networking and enhancing our current MedTech relationships. This focused presence ensures we remain available to support your work without incurring unnecessary costs and passing them on to you. 🤝Reliable Outcomes: By partnering with us, you benefit from our commitment to producing reliable, actionable results. Our team’s expertise in methodological rigor and ethical practices ensures that your research outcomes are dependable and support your strategic objectives. We focus on delivering high-quality results that you can trust for informed decision-making and successful project outcomes. 📆 Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/ePPJX-yn 📰 Share TTi's newsletter with your team. https://lnkd.in/eutCmYBW #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #CVD #Risk #Ethics

With the AdvaMed Conference just days away, we’re excited to highlight how our expertise in digital health & AI can transform your research projects: 📚 User Playbook Development: We created a comprehensive user playbooks that include cost, outcomes, programmatic data, and accounts for heterogeneity across various data sources. This allows healthcare payors and larger employers to evaluate the ROI and impact of your technology - for example, an mHealth-based behavioral counseling program, which is essential for managing chronic conditions often encountered in surgical patients. 🔍Phased Evidence Generation Programs: For a technology using traditional scanners to create 4-dimensional images of the lungs, we developed an evidence generation program and revenue roadmap aimed at improving COPD diagnosis utilizing our capability in the surgical and respiratory fields. 📈Health Economic Models: We have designed HE models for adaptive radiotherapy planning technology, showcasing our ability to integrate advanced AI into surgical applications effectively. Our payer perspective HE models can also inform the development of key value drivers for mHealth and other applications, ensuring that your technology aligns with market needs. 🏥Facility Perspective HE Models: Our facility perspective HE models help develop key value drivers for hospitals - such as for digital therapeutics in oncology practices compared to standard care. . 📑Clinical Dossier Development: We've developed a clinical dossiers for numerous technologies, including a complex, integrated arrhythmia diagnostic system that includes a deep-learning algorithm capable of identifying 12 cardiac rhythms when paired with long-term external monitoring—illustrating our expertise in advanced diagnostic technologies. 💰Reimbursement Landscapes: We have assessed the baseline reimbursement landscape for our clients, including mobile health apps and wearables, and conducted analyses for mobile health applications intended to improve outcomes in hypertension. Our market sizing efforts also extend to wearables for heart failure management, providing you with comprehensive insights. 🔬Clinical Study Design: Our experience in clinical study design and facility perspective HE analysis ensures that your research initiatives are strategically positioned for success in both the surgical and broader healthcare markets. 📆 Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/ePPJX-yn 📰 Share TTi's newsletter with your team. https://lnkd.in/eutCmYBW #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #DigitalHealth #AI #Surgery #Surgical

Effective site selection and management are key to a successful clinical study. Here’s how our strategic approach sets us apart: 📍 Site Selection: We identify and select sites based on their capabilities and patient population. Our strategic team leverages detailed criteria to choose optimal sites, unlike average CROs who may use a more generalized selection process. We also assess site performance to ensure quality. 📝 Site Contracts and Agreements: We handle negotiations and finalize site contracts with precision. Our approach ensures that agreements are tailored to meet both your needs and the sites’, unlike the standard agreements often used by average CROs. We also manage contract modifications efficiently. 🚀 Site Initiation: We conduct thorough site initiation visits to ensure staff are well-trained and protocols are clear. Our strategic team provides comprehensive training and support, surpassing the basic training typically offered by average CROs. We also monitor initial performance closely to address any issues promptly. Our team’s expertise in site management ensures a smooth and effective recruitment process, enhancing the overall success of your study. Next time in part 6 of our strategic clinical studies series, we’ll talk about your study’s data. Collecting it, managing it, site monitoring and more. Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

The AdvaMed MedTech Conference is just around the corner, and we’re excited to showcase how our specialized surgical expertise can elevate your studies. Here’s how we can add value to your research: 🚀Surgical Research Excellence: We excel in conducting high-impact surgical studies using advanced methodologies. Our team includes seasoned experts who have collaborated with top device manufacturers across various surgical domains, including trocars, anesthesia solutions, surgical sealant technologies, and robotics, among many others. This robust experience ensures your study design meets the highest industry standards, driving meaningful advancements in surgical innovation. 🔍Advanced Methodologies: Our approach integrates cutting-edge techniques with comprehensive health economics analysis. We employ skilled researchers and health economists who utilize state-of-the-art tools to address both clinical and economic aspects of your study. 💡Optimized Study Outcomes: We are dedicated to minimizing risks and maximizing the effectiveness of your research. Our strategic approach is supported by a wealth of experience in study design and execution, including retrospective studies that validate definitions of adverse events and demonstrate cost-effectiveness for surgical sealant technologies in gastrectomy procedures. By closely collaborating with you, we ensure that your study outcomes are actionable and valuable in a competitive surgical landscape. 📊Comprehensive Surgical Insights: Our extensive analyses cover various surgical procedures, examining health outcomes and financial impacts associated with diseases of the eye, respiratory diseases, and gender-specific operations. 🔄Innovative Cost-Effectiveness Models: We develop health economic models to demonstrate the cost-effectiveness of new technologies, such as those designed for new disc-preserving discectomies that reduce the risk of re-herniation and associated re-operations. This approach ensures your research addresses both clinical and economic challenges, paving the way for successful market adoption. 📆 Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://zurl.co/V3Go 📰 Share TTi's newsletter with your team. https://zurl.co/qXo6 #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #CVD #Surgery #Surgical

We’re keeping it brief this week. Securing IRB approval is a critical step, and our strategic approach ensures a seamless process. Here’s how we excel in obtaining IRB approval: 📂 IRB Submission Preparation: We prepare and submit all necessary documents for IRB review, including informed consent forms. Unlike average CROs who might provide generic submissions, our strategic team ensures every detail is tailored to meet the IRB’s specific requirements. We also offer guidance on addressing potential IRB concerns. 📅 IRB Review and Approval: We guide you through the IRB review process, ensuring quick and effective responses to any queries. Our proactive and detailed approach contrasts with the more passive methods of average CROs. We also manage follow-ups to ensure timely approval. With our team’s specialized expertise in IRB processes, we help you achieve timely approval, setting the stage for successful site recruitment. Part 5/10 of our strategic clinical studies series is a big one. We’re talking a seemingly difficult step of this journey (that just so happens to be our specialty!) – finding and managing clinical sites! Schedule a chat: discuss your innovation with our VP of Client Relations, Fernanda Nusbaum https://lnkd.in/eT8Ngyn9 TTi's newsletter: Sign up and share! https://lnkd.in/ezh2PSX2 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value

With the AdvaMed conference just two weeks away, we’re excited to showcase how our expertise in women’s health research can elevate your upcoming studies. Our proven experience in this area sets us apart, offering valuable insights for your projects. 🚀 Women’s Health Expertise: TTi Health Research & Economics is renowned for its work in women’s health, tackling unique challenges and opportunities within this field. For instance, our meta-analysis of local invasive breast cancer recurrence after electron intraoperative radiotherapy demonstrated significant insights into recurrence rates, supporting the use of this innovative treatment in early-stage breast cancer care. This experience equips us to navigate regulatory landscapes and market needs with confidence. 🔍 Integrated Approach: We integrate reimbursement and health economics directly into our research strategies. Our work on a study examining the risk of structural birth defects associated with first trimester ondansetron exposure showcases our commitment to rigorous methodologies. By addressing limitations of prior studies and utilizing large population data, we ensure your studies meet payer requirements and market expectations. This comprehensive approach accelerates the research process and enhances its relevance. 💡 Enhanced Results: By leveraging our deep industry knowledge and integrated strategies, we optimize your market positioning and accelerate research outcomes. For example, our collaboration with the CDC on a pilot study addressing women’s health issues in immigrant and refugee populations highlights our ability to create tailored solutions that address specific health concerns. We help you achieve high-quality results that align with your business and patient goals, making a meaningful impact in women’s health. Women's health is near and dear to us. Dr. Zambelli-Weiner an Fernanda Nusbaum are available to discuss how our experience can align with your research goals. We look forward to connecting at the AdvaMed MedTech Conference. Reach out to meet with us during any of the three days. We’re flexible! 📆 Not sure if you're going to make it to the AdvaMed conference? Either way, schedule a time to chat with April and Fernanda via this link or reach out via email. https://lnkd.in/etMpNdCB 📰 Share TTi's newsletter with your team. https://lnkd.in/eBVHvhst #MedTechCon #MTC24 #MedTech #CRO #LitReview #ClinicalResearch #Research #Clinical #StudyManagement #Study #RiskManagement #ValidationStudies #Data #Innovation #MedDevice #EvGen #Evidence #Reimbursement #HECON #HealthEconomics #LitReview #Presentation #Value #Cancer #Womenshealth